These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1565 related items for PubMed ID: 8968696
21. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception. Black A, Guilbert E, Costescu D, Dunn S, Fisher W, Kives S, Mirosh M, Norman W, Pymar H, Reid R, Roy G, Varto H, Waddington A, Wagner MS, Whelan AM, Mansouri S. J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746 [Abstract] [Full Text] [Related]
22. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Backman T. Drug Saf; 2004 Feb; 27(15):1185-204. PubMed ID: 15588115 [Abstract] [Full Text] [Related]
23. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles. Pakarinen PI, Suvisaari J, Luukkainen T, Lähteenmäki P. Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585 [Abstract] [Full Text] [Related]
26. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Sivin I, el Mahgoub S, McCarthy T, Mishell DR, Shoupe D, Alvarez F, Brache V, Jimenez E, Diaz J, Faundes A. Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179 [Abstract] [Full Text] [Related]
27. Selection and performance of the levonorgestrel-releasing intrauterine system. Lähteenmäki P, Bardin CW, Elomaa K, Haukkamaa M, Kivijärvi A, Kuukankorpi A, Venhola M, Tuominen J. Acta Obstet Gynecol Scand Suppl; 1997 Oct; 164():69-74. PubMed ID: 9225643 [Abstract] [Full Text] [Related]
28. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy. French R, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Guillebaud J. Cochrane Database Syst Rev; 2001 Oct; (2):CD001776. PubMed ID: 11406007 [Abstract] [Full Text] [Related]
29. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Dominick S, Hickey M, Chin J, Su HI. Cochrane Database Syst Rev; 2015 Dec 09; 2015(12):CD007245. PubMed ID: 26649916 [Abstract] [Full Text] [Related]
30. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient. Fong YF, Singh K. Contraception; 1999 Jul 09; 60(1):51-3. PubMed ID: 10549453 [Abstract] [Full Text] [Related]
34. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Romero SA, Young K, Hickey M, Su HI. Cochrane Database Syst Rev; 2020 Dec 21; 12(12):CD007245. PubMed ID: 33348436 [Abstract] [Full Text] [Related]
38. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Fong YF, Singh K. Contraception; 1999 Sep 21; 60(3):173-5. PubMed ID: 10640162 [Abstract] [Full Text] [Related]